No Clinically Meaningful Impact of Remibrutinib on Immunoglobulin Levels or Infections in Chronic Spontaneous Urticaria

M. Palumbo, G. Sussman, S. Gogate, A. Fukunaga, S.F. Thomsen, A. Burciu,, P. Wang, M. Maurer

Abstract Poster

REMIX-1/-2: Early Symptom Improvements With Remibrutinib in Chronic Spontaneous Urticaria From Week 1

S. Saini, R. Szalewski, X. Gao, S. Altrichter, S. Haemmerle, N. Seko, M. Hide

Abstract Poster

Clinical Relevance of Urticaria Activity Scores From the Patient Perspective

D. Whalley, S. Sauchelli, M.M. Balp, R. Kohli, P. Orfanos

Abstract Poster

Remibrutinib Provides Fast and Clinically Important Improvement of Chronic Spontaneous Urticaria Disease Activity

J. Jacobs, M. Maurer, A.M. Giménez-Arnau, S. Savic, C-E. Ortmann, B. Suryawanshi, I. Nikolaev,
S. Haemmerle

 Abstract  Poster

Remibrutinib Treatment Has No Impact on Blood Counts in Patients with Chronic Spontaneous Urticaria

J. Leflein, M. Hide, K. Lheritier, S. Haemmerle, M. Wells, M. Kuruvilla, A. Zharkov, A.M. Giménez-Arnau

 Abstract  Poster

Remibrutinib Achieves Clinically Significant Response in Chronic Spontaneous Urticaria Patients Regardless of Prior Oral Treatments

L. Clore, M. Maurer, M. Wells, C-E. Ortmann, B. Suryawanshi, M. Kuruvilla, S. Haemmerle, A.M.Giménez-Arnau

 Abstract  Poster

Analysis Of Safety Data Of Remibrutinib From Completed Phase 2 Studies In Inflammatory Immune-Mediated Diseases

S. Saini, M. Maurer, A.M. Giménez-Arnau, M. Hide, G. Sussman, S. Haemmerle, N. Barbier,
A. Zharkov

 Abstract  Poster

Remibrutinib Treatment Improves Hive Severity in Patients With Chronic Spontaneous Urticaria: Phase 2b Study Results

K. Sitz, A.M. Giménez-Arnau, K. Hayama, V. Jain, K. Lheritier, P. Walsh, S. Haemmerle, M. Maurer

 Abstract  Oral presentation

Remibrutinib Did Not Impact on Total Serum Immunoglobulin Levels of Patients with Chronic Spontaneous Urticaria

W. Carr, A.M. Giménez-Arnau, K. Lheritier, S. Haemmerle, A. Zharkov, S. Dahale, K. Hayama

 Abstract  Poster

Remibrutinib Showed Good Stability of Response in Patients With Chronic Spontaneous Urticaria: Phase 2b Study

J. Tillinghast, V. Jain, M. Maurer, A.M. Giménez-Arnau, A. Reich, C-E. Ortmann, P. Walsh,
S. Haemmerle

 Abstract  Poster

Fast Symptom Improvement and Favorable Safety Profile With Remibrutinib in Chronic Spontaneous Urticaria: REMIX 1 and 2 Studies

S. Saini, A.M. Giménez-Arnau, M. Hide, M. Lebwohl, G. Sussman, A. Barron, S. Haemmerle, I. Hampele, K. Lheritier, E. Martzloff, A. Zharkov, M. Maurer

 Abstract  Oral presentation

Systemic Manifestations During Symptomatic Episodes In Chronic Spontaneous Urticaria: Results From The Urticaria Voices Study

J.A. Bernstein, T.A. Winders, T. Raftery, P. Saraswat, J. McCarthy, M. Kuruvilla, M-M. Balp, K Weller

 Abstract  Poster

The Urticaria Voices Study: Antihistamine Treatment Patterns And Patient Reported Control In Chronic Spontaneous Urticaria

J.A. Bernstein, M-M. Balp, J. McCarthy, M. Kuruvilla, P. Saraswat, T. Raftery, T.A. Winders, K. Weller

 Abstract  Oral presentation